Latest Ishita Drugs & Indus stock price
Ishita Drugs & Indus P/E Ratio
ISHITADR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
26.39
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
26.39
Current Price
₹76.54
EPS (TTM)
₹2.90
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.36
Sector Median
25.87
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Ishita Drugs & Indus
- Stock appears overvalued with PE of 26.39, suggesting caution for new investments
- Trading at discount to sector average PE of 49.36
View the ISHITADR equity price for detailed stock performance.
Related Pages for Ishita Drugs & Indus
Additional stock information and data for ISHITADR
Sector P/E Ratio Comparison
Comparing Ishita Drugs & Indus with other companies in Healthcare sector
Sector Average
49.36
Sector Median
25.87
Lowest P/E
0.97
Highest P/E
993.26
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.67 | ₹1,166 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |